AquaBounty Technologies, Inc. (NASDAQ:AQB) Sees Significant Drop in Short Interest

AquaBounty Technologies, Inc. (NASDAQ:AQB) saw a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 151,800 shares, a decrease of 85.3% from the August 31st total of 1,030,000 shares. Approximately 4.0% of the shares of the stock are sold short. Based on an average daily volume of 2,630,000 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 2,630,000 shares, the short-interest ratio is presently 0.1 days. Approximately 4.0% of the shares of the stock are sold short.

AquaBounty Technologies Stock Performance

AquaBounty Technologies stock opened at $2.85 on Friday. The firm has a market capitalization of $11.06 million, a price-to-earnings ratio of -0.15 and a beta of 1.73. AquaBounty Technologies has a fifty-two week low of $0.47 and a fifty-two week high of $2.95. The stock’s fifty day moving average is $1.13 and its two-hundred day moving average is $0.88.

AquaBounty Technologies (NASDAQ:AQB) last posted its quarterly earnings data on Tuesday, August 5th. The company reported ($0.63) EPS for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.10).

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.